Metastatic liposarcoma is a rare and complex form of cancer that occurs when liposarcoma, a tumor originating in fat cells, spreads beyond its original site to other parts of the body. Understanding this condition, its patterns of spread, and the challenges it presents can help patients and their families navigate the journey ahead with greater awareness and preparation.

Understanding Metastatic Liposarcoma

Liposarcoma is itself an uncommon type of cancer that begins in fat cells located in deep soft tissues throughout the body. When we talk about metastatic liposarcoma, we are referring to a situation where the cancer has traveled from where it first formed to distant organs or tissues. This represents an advanced stage of the disease and brings with it different treatment considerations and outcomes compared to cancer that remains in one place.^[5]

The behavior and spread patterns of liposarcoma depend heavily on which subtype a person has. There are several distinct types of liposarcoma, and each one has its own characteristics when it comes to how likely it is to spread to other parts of the body. Some types are locally aggressive but rarely spread distantly, while others have a greater tendency to metastasize and require more intensive monitoring and treatment.^[4][13]

Epidemiology and Who Is Affected

Liposarcoma as a whole represents less than 20 percent of all soft tissue sarcomas diagnosed in the United States. This makes it a relatively rare cancer, though it is actually the most common type of soft tissue sarcoma worldwide. The average age at which people are diagnosed with liposarcoma is around 50 years old, though cases have been reported in children as well, particularly during adolescence.^[2][7]

When looking at who develops this disease, there does not appear to be a strong association with race. However, some studies have noted a slight male predominance, meaning men may be somewhat more likely than women to develop liposarcoma. Most cases occur in adults between the ages of 50 and 65, though one particular subtype called myxoid liposarcoma tends to affect people between ages 35 and 55.^[2][4]

The incidence of liposarcoma in the United States is approximately 1 in 100,000 people each year. When we consider that about 2,000 people are affected annually across the country, it becomes clear just how rare this condition truly is. For metastatic disease specifically, statistics show that roughly 10 percent of patients present with synchronous metastatic disease at the time of their initial diagnosis, meaning the cancer has already spread when it is first discovered.^[4][19]

Causes and Risk Factors

The exact cause of liposarcoma remains unknown to medical researchers. Scientists are still investigating the specific genetic mutations that lead to these malignancies. What makes understanding the causes even more challenging is that many patients diagnosed with liposarcoma have no apparent risk factors for the disease at all.^[2]

The American Cancer Society has identified several risk factors that may increase the likelihood of developing soft tissue sarcomas, including liposarcoma. One significant risk factor is previous exposure to radiation, particularly radiation therapy used to treat other cancers. When someone has undergone radiation treatment in the past, the tissues that received radiation may have an increased risk of developing sarcoma years later.^[2]

Certain inherited family cancer syndromes can also increase risk. These are genetic conditions passed down through families that make individuals more susceptible to various types of cancer. Damage or trauma to the lymphatic system is another identified risk factor. The lymphatic system is part of the body’s immune system and helps remove waste and toxins. When it becomes damaged, there may be changes that can contribute to cancer development.^[2]

Exposure to toxic chemicals has also been linked to an increased risk of soft tissue sarcomas. However, it is important to emphasize that having one or more risk factors does not mean a person will definitely develop liposarcoma. Many people with risk factors never develop the disease, and many who do develop it have no known risk factors.

Symptoms of Metastatic Liposarcoma

The symptoms of metastatic liposarcoma depend largely on where the cancer has spread. The original tumor typically develops in the arms, legs, or abdomen, and early-stage liposarcomas often grow very slowly without causing pain. Many people do not notice any symptoms until the tumor becomes large enough to press on surrounding tissues or organs.^[3][4]

When liposarcoma forms in the arms or legs, the most common symptom is a growing lump of tissue under the skin. This lump typically does not go away and may gradually increase in size. If the tumor presses on a nerve, it can cause pain in the affected area. Swelling may develop around the tumor, and some people experience weakness in the affected limb, making it difficult to use the arm or leg normally.^[3][7]

Liposarcoma that develops in the abdomen, also called the retroperitoneum (the space at the back of the abdominal cavity), can cause a different set of symptoms. People may experience abdominal pain or cramping that persists over time. The abdomen may become swollen or distended as the tumor grows larger. Some people notice they feel full sooner when eating, even after consuming only small amounts of food. Digestive symptoms such as constipation may occur if the tumor presses on the intestines. In some cases, blood may appear in the stool, which can be bright red or cause the stool to look black and tarry. Nausea and unintended weight loss are also possible symptoms.^[3][7]

When liposarcoma has metastasized to other organs, symptoms will reflect the location of the spread. For example, if the cancer has spread to the lungs, which is one of the most common sites of metastasis, a person may experience difficulty breathing or shortness of breath. The lungs are where about 50 percent of patients with high-grade soft tissue sarcoma eventually develop metastases. In many of these cases, the lungs remain the only site of metastatic disease.^[19]

Some people with metastatic liposarcoma experience general symptoms that are not specific to any one location. These can include fevers, chills, fatigue that does not improve with rest, night sweats, and weight loss that occurs without trying to lose weight. These systemic symptoms indicate that the cancer is affecting the body as a whole.^[7]

Different Types and Their Metastatic Potential

Understanding the different subtypes of liposarcoma is crucial because each type behaves differently and has varying potential to spread. The four main subtypes occur on a spectrum of biological activity and metastatic potential, with the predominant cause of sarcoma-specific death being locoregional recurrence, meaning the cancer returns in or near the original site.^[5]

Well-differentiated liposarcoma, which accounts for 30 to 50 percent of all liposarcomas, is the most common type. These are slow-growing, painless tumors that may appear in the arms, legs, or trunk. Healthcare providers sometimes call them atypical lipomatous tumors. A key characteristic of well-differentiated liposarcoma is that while it is locally aggressive, it is actually incapable of metastasis. This means that pure well-differentiated liposarcoma does not spread to distant organs, though it can recur locally even many years after treatment.^[4][13][5]

Dedifferentiated liposarcoma represents well-differentiated liposarcoma’s more aggressive counterpart. Some people with well-differentiated liposarcoma develop dedifferentiated areas within the tumor or experience transformation over time. Unlike its predecessor, dedifferentiated liposarcoma is both locally aggressive and capable of distant metastasis, primarily to the lung. This subtype has a greater chance of both local recurrence and metastasis than other subtypes. Studies show that recurrence occurs in 40 to 75 percent of dedifferentiated liposarcoma cases, and metastasis occurs in about 10 to 15 percent of cases.^[4][8][5]

Myxoid and round cell liposarcoma are considered part of a single histology whose metastatic potential occurs on a spectrum. These account for about 30 percent of all liposarcomas and are the second most common types. Unlike other subtypes, myxoid liposarcoma may affect people between ages 35 and 55, making it somewhat unique in its age distribution. The round cell component refers to how the tumor cells appear under a microscope, and its presence is considered an adverse prognostic sign. When round cell features are present, the tumor tends to be more aggressive. Myxoid liposarcoma has unusual metastatic patterns, spreading not just to the lungs but also to the spine, axillary fat pads (areas under the arms), and the retroperitoneal fat. It can also spread to bones, such as pelvic bones or the spine, or to organs including the heart, lungs, or esophagus.^{[4][13][5][6]}

Pleomorphic liposarcoma is the most aggressive subtype. It metastasizes early in its course and has a very poor prognosis. This type can grow very fast and quickly spread from where it started to other areas of the body. Fortunately, it is also one of the rarer subtypes, accounting for a smaller percentage of all liposarcoma cases.^[4][5]

Pathophysiology: How Metastatic Liposarcoma Affects the Body

When liposarcoma becomes metastatic, it means that cancer cells have broken away from the original tumor and traveled through the body to establish new tumors in distant locations. This process involves complex biological mechanisms that researchers are still working to fully understand.

Research suggests that metastasis of well-differentiated and dedifferentiated liposarcoma may be mediated by extracellular vesicles, which are tiny bubble-like structures released by cells. These vesicles contain active genetic material and can condition both the local tumor environment and the distant premetastatic niche to support tumor growth. In simpler terms, the original tumor may be sending out signals and materials that prepare distant sites in the body to receive and support the growth of cancer cells before they even arrive. This preparation of distant sites is thought to make it easier for metastatic tumors to take hold and grow.^[5]

The physical impact of metastatic liposarcoma depends on where the tumors develop. When tumors grow in the lungs, they can interfere with normal breathing by taking up space that should be filled with healthy lung tissue. This reduces the lungs’ capacity to exchange oxygen and carbon dioxide, leading to shortness of breath and difficulty breathing, especially during physical activity.

When metastases occur in bones, they can weaken the bone structure, potentially leading to fractures. Bone metastases can also be quite painful, as the growing tumor puts pressure on the bone and surrounding tissues. In the spine, metastases can be particularly concerning because they may compress the spinal cord or nerves, potentially causing pain, numbness, weakness, or even paralysis if not treated promptly.

Metastases to soft tissues, fat pads, or the retroperitoneum can cause local symptoms depending on their size and exact location. Large tumors may press on nearby organs, blood vessels, or nerves, interfering with their normal function. In the retroperitoneum, growing tumors can compress the kidneys, intestines, or major blood vessels, leading to various complications.

At a cellular level, liposarcoma involves the abnormal growth and multiplication of cells that should normally develop into fat tissue. In well-differentiated and dedifferentiated types, genetic analysis has identified aberrations in chromosome 12q13-15 involving oncogenes including CDK4 and MDM2. These genetic changes drive the uncontrolled cell growth that characterizes cancer.^[9]

Prevention

Because the exact causes of liposarcoma are not fully understood, there are no proven strategies to prevent the disease from developing. However, understanding and avoiding known risk factors may help reduce risk to some extent.

For people who require radiation therapy for another cancer, the benefits of that treatment typically far outweigh the potential risk of developing a secondary cancer like liposarcoma years later. However, radiation oncologists work carefully to minimize exposure to healthy tissues during treatment, which may help reduce this risk.

People with known family cancer syndromes that increase sarcoma risk should work closely with genetic counselors and healthcare providers. Regular monitoring and early detection strategies may be recommended for these individuals, though this does not prevent the disease so much as catch it early when it is most treatable.

Avoiding exposure to toxic chemicals, when possible, is a reasonable general health precaution. This might include using proper protective equipment when working with hazardous materials and following safety guidelines in occupational settings where chemical exposure is possible.

For patients who have been treated for localized liposarcoma, preventing metastasis becomes a key concern. The most important preventive measure is adherence to recommended follow-up care. Regular surveillance with physical examinations and imaging studies can detect recurrence or metastasis early, when treatment options may be more effective. Well-differentiated liposarcoma has a high local recurrence rate of about 10 percent, even up to 25 years after surgical removal, which underscores the importance of long-term follow-up.^[2]

Complete surgical removal of the tumor with clear margins (meaning normal tissue around the tumor is also removed) is crucial for preventing both local recurrence and potential metastasis. When surgeons can achieve wide margins, the risk of the cancer coming back decreases significantly. In some cases, radiation therapy or chemotherapy may be recommended after surgery to reduce the risk of recurrence or spread.^[8]